|
|
Article: Nucleotech Reprograms Skin Cells Directly Into Immune-Like Cells In Vitro; Report in Nature Biotechnology Highlights Potential New Approach for Cell Therapy Using Mature Cells.
- Article from:
- Business Wire
- Article date:
- May 1, 2002
CopyrightCOPYRIGHT 2002 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors & Health/Medical Writers
BIOWIRE2K
WESPORT, Conn.--(BW HealthWire)--May 1, 2002
Scientists at Nucleotech, LLC, a company pioneering the development of autologous cell-based therapeutics, today announced the successful reprogramming of mature skin cells (fibroblasts) directly into immune-like cells. The immune-like cells expressed a wide variety of immune cell genes and showed evidence of complex functions characteristic of immune cells. These laboratory studies are the first to demonstrate the potential of the Company's novel transdifferentiation (cell reprogramming) approach and create new opportunities for directly replacing ...